# Efficacy of N-acetylcysteine Versus Placebo as Prophylaxis of Sinusoidal Obstruction Syndrome in Patients Undergoing Hematopoietic Stem Cell Transplantation

> **NCT04712435** · PHASE2 · UNKNOWN · sponsor: **Instituto Brasileiro de Controle do Cancer** · enrollment: 80 (estimated)

## Conditions studied

- Sinusoidal Obstruction Syndrome (SOS)
- Hematopoietic Stem Cell Transplant (HSCT)

## Interventions

- **DRUG:** N-acetylcysteine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04712435
- **Lead sponsor:** Instituto Brasileiro de Controle do Cancer
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-03-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2021-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04712435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04712435, "Efficacy of N-acetylcysteine Versus Placebo as Prophylaxis of Sinusoidal Obstruction Syndrome in Patients Undergoing Hematopoietic Stem Cell Transplantation". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04712435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*